The first-in-class ruthenium-based chemotherapeutic agent BOLD-100 (formerly IT-139. NKP-1339. KP1339) is currently the subject of clinical evaluation for the treatment of gastric. pancreatic. https://stilleners.shop/product-category/lowering-kits/